Literature DB >> 32072769

Restricted mean survival time as a summary measure of time-to-event outcome.

Takahiro Hasegawa1, Saori Misawa2, Shintaro Nakagawa3, Shinichi Tanaka4, Takanori Tanase5, Hiroyuki Ugai6, Akira Wakana7, Yasuhide Yodo8, Satoru Tsuchiya8, Hideki Suganami9.   

Abstract

Many clinical research studies evaluate a time-to-event outcome, illustrate survival functions, and conventionally report estimated hazard ratios to express the magnitude of the treatment effect when comparing between groups. However, it may not be straightforward to interpret the hazard ratio clinically and statistically when the proportional hazards assumption is invalid. In some recent papers published in clinical journals, the use of restricted mean survival time (RMST) or τ-year mean survival time is discussed as one of the alternative summary measures for the time-to-event outcome. The RMST is defined as the expected value of time to event limited to a specific time point corresponding to the area under the survival curve up to the specific time point. This article summarizes the necessary information to conduct statistical analysis using the RMST, including the definition and statistical properties of the RMST, adjusted analysis methods, sample size calculation, information fraction for the RMST difference, and clinical and statistical meaning and interpretation. Additionally, we discuss how to set the specific time point to define the RMST from two main points of view. We also provide developed SAS codes to determine the sample size required to detect an expected RMST difference with appropriate power and reconstruct individual survival data to estimate an RMST reference value from a reported survival curve.
© 2020 John Wiley & Sons Ltd.

Keywords:  proportional hazards assumption; restricted mean survival time; summary measure; survival analysis; time-to-event data

Mesh:

Year:  2020        PMID: 32072769     DOI: 10.1002/pst.2004

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  4 in total

1.  Restricted mean survival time regression model with time-dependent covariates.

Authors:  Chengfeng Zhang; Baoyi Huang; Hongji Wu; Hao Yuan; Yawen Hou; Zheng Chen
Journal:  Stat Med       Date:  2022-06-23       Impact factor: 2.497

2.  Focused Information Criterion for Restricted Mean Survival Times: Non-Parametric or Parametric Estimators.

Authors:  Szilárd Nemes; Andreas Gustavsson; Alexandra Jauhiainen
Journal:  Entropy (Basel)       Date:  2022-05-16       Impact factor: 2.738

3.  Statistical Considerations for Sequential Analysis of the Restricted Mean Survival Time for Randomized Clinical Trials.

Authors:  Ying Lu; Lu Tian
Journal:  Stat Biopharm Res       Date:  2020-10-09       Impact factor: 1.452

4.  Fast pain relief in exercise-induced acute musculoskeletal pain by turmeric-boswellia formulation: A randomized placebo-controlled double-blinded multicentre study.

Authors:  Girish H Rudrappa; Meghana Murthy; Santosh Saklecha; Sanjeev Kumar Kare; Ajay Gupta; Indraneel Basu
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.